Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Clinical trial NCT02251704 · COMPLETED

Trial details

NCT number: NCT02251704
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Malaria Malaria Vaccines

Start date: 2014-10-22
Primary completion: 2024-07-06
Enrollment: 54115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.